Home > Insider Trading > Bioamber Inc. > Profile

Bioamber Inc. (BIOA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Related Insiders

P Richard Eno, Chief Executive Officer, 2018-04-03
W. Kenneth Wall, Director, 2017-12-04
A. Michael Hartmann, Executive Vice President, 2017-08-22

P Richard Eno, Chief Executive Officer, 2018-04-03
W. Kenneth Wall, Director, 2017-12-04
A. Michael Hartmann, Executive Vice President, 2017-08-22
Heinz Haller, Director, 2017-08-16
W Kurt Briner, Director, 2017-08-16
James Millis, Chief Technology Officer, 2017-08-16
B Ellen Richstone, Director, 2017-08-16
Mario Settino, Chief Financial Officer, 2017-08-16
J Raymond Land, Director, 2017-08-16
Fabrice Orecchioni, Chief Operations Officer, 2017-08-16
Robert Frost, Director, 2017-06-09
Mario Saucier, Chief Financial Officer, 2017-02-13
John Frederick George Gosbee, Director, 2016-11-14
Jean-Francois Huc, President And Ceo, 2016-05-11
Babette Pettersen, Chief Commercial Officer, 2016-01-27
P. Andrew Ashworth, Chief Financial Officer, 2015-09-01
Jr Henry Linsert, Director, 2015-05-19
Francois Laurin, Chief Financial Officer, 2015-05-08
Denis Lucquin, Director, 2014-05-29
Jorge Nogueira, Director, 2014-02-14
H William Camp, Director, 2014-02-14
R.l. S.a Managers Capital Naxos, Large Shareholder, 2013-05-16
S.a. Naxamber, Large Shareholder, 2013-05-16
Sicar Sca Partners Capital Naxos, Large Shareholder, 2013-05-16
Sas Partners Sofinnova, Large Shareholder, 2013-05-16
Fcpr Vi Capital Sofinnova, Large Shareholder, 2013-05-16
Mitsui & Co Ltd, Large Shareholder, 2013-05-10
Mcvp Technology Fund I, Llc, Large Shareholder, 2013-05-10

Show All Insiders (28)

Hedge Fund Popularity

Display

13F filing is ongoing

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on July 23, 2019, 2:40 pm based on SEC 13F filings Last update: July 23, 2019, 2:40 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Levin Capital Strategies John A. Levin	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Wall Director	$0.43	40,000	$17,200.00	170,443	2017-11-30	Filing
Hartmann Officer	$0.48	10,000	$4,750.00	153,476	2017-08-18	Filing
Haller Director	$0.00	40,000	$0.00	50,000	2017-08-15	Filing
Briner Director	$0.00	133,333	$0.00	285,978	2017-08-15	Filing
Millis Officer	$0.00	13,333	$0.00	14,433	2017-08-15	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Hartmann Officer	$8.11	21,477	$174,178.47	123,143	2015-12-03	Filing
Huc Officer, Director	$8.11	27,278	$221,224.58	144,222	2015-12-03	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	First Midwest Bank Trust Division	0	$0	0%

News See All

BioAge Labs, Inc. (BIOA)’s BGE-102 Shows Potent Weight Loss, Plans IND Submission Mid-2025

BioAge Labs, Inc. (NASDAQ:BIOA), a clinical-stage biotech innovator, announced today the completion of IND-enabling studies for its groundbreaking oral NLRP3 inhibitor, BGE-102, targeting obesity.

Keep Reading →

May 29th, 2025 - News

BioAge Labs, Inc. (BIOA): A Bull Case Theory

We came across a bullish thesis on BioAge Labs, Inc. (BIOA) on Substack by Ragnarok Research. In this article, we will summarize the bulls’ thesis on BIOA. BioAge Labs, Inc.

Keep Reading →

April 21st, 2025 - News Stock Analysis

BioAge Labs, Inc. (BIOA): A Bull Case Theory

We came across a bullish thesis on BioAge Labs, Inc. (NASDAQ:BIOA) on Value Investing Subreddit Page by value1024. In this article, we will summarize the bulls’ thesis on BIOA. BioAge Labs, Inc.

Keep Reading →

December 27th, 2024 - News Stock Analysis

10 Best All-Time Low Stocks To Buy Right Now

With November coming to a close, while markets are focused on the future of artificial intelligence and the degree of profitability that AI firms can extract from their multi-billion dollar investments...

Keep Reading →

December 4th, 2024 - Hedge Funds News

13G Filing: Sabby Capital and Bioamber Inc. (BIOA)

Bioamber Inc. (NYSE:BIOA): Hal Mintz's Sabby Capital filed an amended 13D. You can check out Sabby Capital's latest holdings and filings here.

Keep Reading →

September 12th, 2017 - Hedge Funds

Bioamber Inc (BIOA): How It Stacks Up Against Its Peers

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.

Keep Reading →

December 14th, 2016 - Hedge Funds News

What's the Deal With These Stocks Getting Pounded?

It's been a Friday to forget for many bullish investors as the NASDAQ index opened in the red and continues to decline in late morning trading as valuation worries and concerns about the global economy...

Keep Reading →

January 15th, 2016 - Market Movers News